首页> 外文期刊>Journal of Agricultural and Food Chemistry >Enhanced Oral Bioavailability and Antioxidant Profile of Ellagic Acid by Phospholipids
【24h】

Enhanced Oral Bioavailability and Antioxidant Profile of Ellagic Acid by Phospholipids

机译:磷脂提高了鞣花酸的口服生物利用度和抗氧化特性

获取原文
获取原文并翻译 | 示例
       

摘要

Ellagic acid (EA) has been reported as a potent antioxidant from natural resources with several nutritional benefits. The major disadvantage of this phytoconstituent is its rapid elimination from the body after administration. To overcome this limitation, a novel dietary formulation of EA with phospholipid was developed to investigate the effect of this complex on carbon tetrachloride induced liver damage in rats. The antioxidant activity of the complex (equivalent of EA = 25 and 50 mg/kg of body weight) and free EA (25 and 50 mg/kg of body weight) was evaluated by measuring various enzymes in oxidative stress condition. The complex significantly protected the liver by restoring the activity of superoxide dismutase, catalase and liver glutathione, and thiobarbi-turic acid reactive substances with respect to the carbon tetrachloride treated group (P < 0.05 and < 0.01). The complex provided better protection to rat liver than free EA at the same dose. The serum concentration of EA obtained from the complex (equivalent to 80 mg/kg of EA) was higher (C_(max) = 0.54 μ g/mL) than that of pure EA (80 mg/kg) (C_(max) = 0.21 μg /mL), and the complex maintained effective concentration for a longer period of time in serum. The experimental outcome highlighted better hepatoprotective activity of the EA complex due to its potential antioxidant property compared with the free EA tested at the same dose level.
机译:据报道,鞣花酸(EA)是一种有效的抗氧化剂,来自自然资源,具有多种营养益处。这种植物成分的主要缺点是给药后迅速从体内清除。为了克服这一局限性,开发了一种具有磷脂的EA新型饮食配方,以研究该复合物对四氯化碳诱导的大鼠肝损伤的影响。通过在氧化应激条件下测量各种酶来评估复合物(相当于EA = 25和50 mg / kg体重)和游离EA(25和50 mg / kg体重)的抗氧化活性。相对于四氯化碳治疗组,该复合物通过恢复超氧化物歧化酶,过氧化氢酶和肝脏谷胱甘肽和硫代比比妥酸反应性物质的活性来显着保护肝脏(P <0.05和<0.01)。与相同剂量的游离EA相比,该复合物对大鼠肝脏的保护作用更好。从复合物中获得的EA的血清浓度(相当于80 mg / kg EA)(C_(max)= 0.54μg / mL)高于纯EA(80 mg / kg)(C_(max)= 0.21μg/ mL),并且该复合物在血清中维持了更长的有效浓度。实验结果表明,与在相同剂量水平下测试的游离EA相比,EA复合物具有潜在的抗氧化特性,因此具有更好的肝保护活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号